2015-2025 Global Opioids Drug Market Research by Type, End-Use and Region (COVID-19 Version)

Publisher Name :
Date: 24-Aug-2020
No. of pages: 110

Summary

Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin ), hydrocodone (Vicodin ), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.

The global Opioids Drug market is expected to reach xxx Million USD by 2025, with a CAGR of xx% from 2020 to 2025.

Further key aspects of the report indicate that:

Chapter 1: Market Definition and Segment by Type, End-Use & Major Regions Market Size

Chapter 2: Global Production & Consumption Market by Type and End-Use

Chapter 3: Europe Production & Consumption Market by Type and End-Use

Chapter 4: America Production & Consumption Market by Type and End-Use

Chapter 5: Asia Production & Consumption Market by Type and End-Use

Chapter 6: Oceania Production & Consumption Market by Type and End-Use

Chapter 7: Africa Production & Consumption Market by Type and End-Use

Chapter 8: Global Market Forecast by Type, End-Use and Region

Chapter 9: Company information, Sales, Cost, Margin, news etc.

Chapter 10: Market Competition by Companies and Market Concentration Ratio

Chapter 11: Market Impact by Coronavirus.

Chapter 12: Industry Summary

Market Segment as follows:

Key Companies

- Purdue Pharma

- J&J

- Teva

- Mylan

- Depomed

- INSYS

- Endo

- Pfizer

- Hikma

- Mallinckrodt

- Pernix

- Egalet

- Vistapharm

Key Types

- Oxycodone

- Hydromorphone

- Codeine

- Fentanyl

- Others

Key End-Use

- Pain Relief

- Anesthesia

- Others

This report can be dispatched within 24-48 Hours.

2015-2025 Global Opioids Drug Market Research by Type, End-Use and Region (COVID-19 Version)

Table of Contents

CHAPTER 1 MARKET OVERVIEW
1.1 Market Definition and Segment
1.1.1 Product Definition
1.1.2 Product Type
1.1.3 End-Use
1.1.4 Marketing Channel
1.2 Major Regions
1.2.1 Europe Market Size and Growth
Figure Europe Opioids Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Opioids Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.2 America Market Size and Growth
Figure America Opioids Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Opioids Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.3 Asia Market Size and Growth
Figure Asia Opioids Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaOpioids Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.4 Oceania Market Size and Growth
Figure Oceania Opioids Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Opioids Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
1.2.5 Africa Market Size and Growth
Figure Africa Opioids Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Opioids Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
CHAPTER 2 GLOBAL MARKET SEGMENTATION
2.1 Global Production Overview
Table Global Opioids Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
2.2 Global Consumption Overview
Table Global Opioids Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
2.3 Global Production by Type
Table Global Opioids Drug Revenue by Type, 2015-2020 (Million USD)
Figure Global Opioids Drug Revenue Share by Type in 2020 (Million USD)
Table Global Opioids Drug Production Volume by Type, 2015-2020 (Volume)
Figure Global Opioids Drug Production Volume Share by Type in 2020 (Volume)
2.4 Global Consumption by End-Use
Table Global Opioids Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Global Opioids Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Global Opioids Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Global Opioids Drug Consumption Volume Share by End-Use in 2020 (Volume)
2.5 Global Consumption by Region
Table Global Opioids Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Opioids Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 3 Europe MARKET SEGMENTATION
3.1 Europe Production Overview
Table Europe Opioids Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
3.2 Europe Consumption Overview
Table Europe Opioids Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
3.3 Europe Production by Type
Table Europe Opioids Drug Revenue by Type, 2015-2020 (Million USD)
Figure Europe Opioids Drug Revenue Share by Type in 2020 (Million USD)
Table Europe Opioids Drug Production Volume by Type, 2015-2020 (Volume)
Figure Europe Opioids Drug Production Volume Share by Type in 2020 (Volume)
3.4 Europe Consumption by End-Use
Table Europe Opioids Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Europe Opioids Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Europe Opioids Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Europe Opioids Drug Consumption Volume Share by End-Use in 2020 (Volume)
3.5 Europe Consumption by Region
Table Europe Opioids Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Opioids Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 4 AMERICA MARKET SEGMENTATION
4.1 America Production Overview
Table America Opioids Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
4.2 America Consumption Overview
Table America Opioids Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
4.3 America Production by Type
Table America Opioids Drug Revenue by Type, 2015-2020 (Million USD)
Figure America Opioids Drug Revenue Share by Type in 2020 (Million USD)
Table America Opioids Drug Production Volume by Type, 2015-2020 (Volume)
Figure America Opioids Drug Production Volume Share by Type in 2020 (Volume)
4.4 America Consumption by End-Use
Table America Opioids Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure America Opioids Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table America Opioids Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure America Opioids Drug Consumption Volume Share by End-Use in 2020 (Volume)
4.5 America Consumption by Region
Table America Opioids Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Opioids Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 5 ASIA MARKET SEGMENTATION
5.1 Asia Production Overview
Table Asia Opioids Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
5.2 Asia Consumption Overview
Table Asia Opioids Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
5.3 Asia Production by Type
Table Asia Opioids Drug Revenue by Type, 2015-2020 (Million USD)
Figure Asia Opioids Drug Revenue Share by Type in 2020 (Million USD)
Table Asia Opioids Drug Production Volume by Type, 2015-2020 (Volume)
Figure Asia Opioids Drug Production Volume Share by Type in 2020 (Volume)
5.4 Asia Consumption by End-Use
Table Asia Opioids Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Asia Opioids Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Asia Opioids Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Asia Opioids Drug Consumption Volume Share by End-Use in 2020 (Volume)
5.5 Asia Consumption by Region
Table Asia Opioids Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Opioids Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 6 OCEANIA MARKET SEGMENTATION
6.1 Oceania Production Overview
Table Oceania Opioids Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
6.2 Oceania Consumption Overview
Table Oceania Opioids Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
6.3 Oceania Production by Type
Table Oceania Opioids Drug Revenue by Type, 2015-2020 (Million USD)
Figure Oceania Opioids Drug Revenue Share by Type in 2020 (Million USD)
Table Oceania Opioids Drug Production Volume by Type, 2015-2020 (Volume)
Figure Oceania Opioids Drug Production Volume Share by Type in 2020 (Volume)
6.4 Oceania Consumption by End-Use
Table Oceania Opioids Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Oceania Opioids Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Oceania Opioids Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Oceania Opioids Drug Consumption Volume Share by End-Use in 2020 (Volume)
6.5 Oceania Consumption by Region
Table Oceania Opioids Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Opioids Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 7 AFRICA MARKET SEGMENTATION
7.1 Africa Production Overview
Table Africa Opioids Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
7.2 Africa Consumption Overview
Table Africa Opioids Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
7.3 Africa Production by Type
Table Africa Opioids Drug Revenue by Type, 2015-2020 (Million USD)
Figure Africa Opioids Drug Revenue Share by Type in 2020 (Million USD)
Table Africa Opioids Drug Production Volume by Type, 2015-2020 (Volume)
Figure Africa Opioids Drug Production Volume Share by Type in 2020 (Volume)
7.4 Africa Consumption by End-Use
Table Africa Opioids Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Figure Africa Opioids Drug Consumption Value Share by End-Use in 2020 (Million USD)
Table Africa Opioids Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Figure Africa Opioids Drug Consumption Volume Share by End-Use in 2020 (Volume)
7.5 Africa Consumption by Region
Table Africa Opioids Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Opioids Drug Consumption Volume by Region, 2015-2020 (Volume)
CHAPTER 8 GLOBAL MARKET FORECAST
8.1 Global Opioids Drug Production Forecast
Figure Global Opioids Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Opioids Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
8.2 Global Opioids Drug Forecast by Type
Table Global Opioids Drug Revenue by Type, 2020E-2025F (Million USD)
Figure Global Opioids Drug Revenue Share by Type in 2025 (Million USD)
Table Global Opioids Drug Production Volume by Type, 2020E-2025F (Volume)
Figure Global Opioids Drug Production Volume Share by Type in 2025 (Volume)
8.3 Global Opioids Drug Forecast by End-Use (2020E-2025F)
Table Global Opioids Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Figure Global Opioids Drug Consumption Value Share by End-Use in 2025 (Million USD)
Table Global Opioids Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
8.4 Global Opioids Drug Forecast by Region (2020E-2025F)
Table Global Opioids Drug Consumption Value by Region, 2020E-2025F (Million USD)
Figure Global Opioids Drug Consumption Value Share by Region in 2025 (Million USD)
Table Global Opioids Drug Consumption Volume by Region, 2020E-2025F (Volume)
Figure Global Opioids Drug Consumption Volume Share by Region in 2025 (Volume)
CHAPTER 9 GLOBAL MAJOR COMPANIES LIST
9.1 Purdue Pharma
9.1.1 Purdue Pharma Profile
Table Purdue Pharma Overview List
9.1.2 Purdue Pharma Products & Services
9.1.3 Purdue Pharma Company Dynamics & News
9.1.4 Purdue Pharma Business Operation Conditions
Table Business Operation of Purdue Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.2 J&J
9.2.1 J&J Profile
Table J&J Overview List
9.2.2 J&J Products & Services
9.2.3 J&J Company Dynamics & News
9.2.4 J&J Business Operation Conditions
Table Business Operation of J&J (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.3 Teva
9.3.1 Teva Profile
Table Teva Overview List
9.3.2 Teva Products & Services
9.3.3 Teva Company Dynamics & News
9.3.4 Teva Business Operation Conditions
Table Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.4 Mylan
9.4.1 Mylan Profile
Table Mylan Overview List
9.4.2 Mylan Products & Services
9.4.3 Mylan Company Dynamics & News
9.4.4 Mylan Business Operation Conditions
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.5 Depomed
9.5.1 Depomed Profile
Table Depomed Overview List
9.5.2 Depomed Products & Services
9.5.3 Depomed Company Dynamics & News
9.5.4 Depomed Business Operation Conditions
Table Business Operation of Depomed (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.6 INSYS
9.6.1 INSYS Profile
Table INSYS Overview List
9.6.2 INSYS Products & Services
9.6.3 INSYS Company Dynamics & News
9.6.4 INSYS Business Operation Conditions
Table Business Operation of INSYS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.7 Endo
9.7.1 Endo Profile
Table Endo Overview List
9.7.2 Endo Products & Services
9.7.3 Endo Company Dynamics & News
9.7.4 Endo Business Operation Conditions
Table Business Operation of Endo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.8 Pfizer
9.8.1 Pfizer Profile
Table Pfizer Overview List
9.8.2 Pfizer Products & Services
9.8.3 Pfizer Company Dynamics & News
9.8.4 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.9 Hikma
9.9.1 Hikma Profile
Table Hikma Overview List
9.9.2 Hikma Products & Services
9.9.3 Hikma Company Dynamics & News
9.9.4 Hikma Business Operation Conditions
Table Business Operation of Hikma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.10 Mallinckrodt
9.10.1 Mallinckrodt Profile
Table Mallinckrodt Overview List
9.10.2 Mallinckrodt Products & Services
9.10.3 Mallinckrodt Company Dynamics & News
9.10.4 Mallinckrodt Business Operation Conditions
Table Business Operation of Mallinckrodt (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.11 Pernix
9.11.1 Pernix Profile
Table Pernix Overview List
9.11.2 Pernix Products & Services
9.11.3 Pernix Company Dynamics & News
9.11.4 Pernix Business Operation Conditions
Table Business Operation of Pernix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9.12 Egalet
9.12.1 Egalet Profile
Table Egalet Overview List
9.12.2 Egalet Products & Services
9.12.3 Egalet Company Dynamics & News
9.12.4 Egalet Business Operation Conditions
Table Business Operation of Egalet (Sales Revenue, Cost, Gross Margin)
9.13 Vistapharm
9.13.1 Vistapharm Profile
Table Vistapharm Overview List
9.13.2 Vistapharm Products & Services
9.13.3 Vistapharm Company Dynamics & News
9.13.4 Vistapharm Business Operation Conditions
Table Business Operation of Vistapharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
PART 10 MARKET COMPETITION
10.1 Key Company Market Share
Table Global Opioids Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Opioids Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Opioids Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Opioids Drug Sales Volume Share by Companies, 2015-2020E (Volume)
10.2 Regional Market Concentration
Figure Europe Opioids Drug Market Concentration Ratio in 2020E
Figure America Opioids Drug Market Concentration Ratio in 2020E
Figure Asia Opioids Drug Market Concentration Ratio in 2020E
Figure Oceania Opioids Drug Market Concentration Ratio in 2020E
Figure Africa Opioids Drug Market Concentration Ratio in 2020E
PART 11 CORONAVIRUS IMPACT ON Opioids Drug INDUSTRY
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
PART 12 Opioids Drug INDUSTRY SUMMARY & CONCLUSION

List of Tables

Table Global Opioids Drug Revenue by Type, 2015-2020 (Million USD)
Table Global Opioids Drug Production Volume by Type, 2015-2020 (Volume)
Table Global Opioids Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Global Opioids Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Global Opioids Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Global Opioids Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Europe Opioids Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Europe Opioids Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Europe Opioids Drug Revenue by Type, 2015-2020 (Million USD)
Table Europe Opioids Drug Production Volume by Type, 2015-2020 (Volume)
Table Europe Opioids Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Europe Opioids Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Europe Opioids Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Europe Opioids Drug Consumption Volume by Region, 2015-2020 (Volume)
Table America Opioids Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table America Opioids Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table America Opioids Drug Revenue by Type, 2015-2020 (Million USD)
Table America Opioids Drug Production Volume by Type, 2015-2020 (Volume)
Table America Opioids Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table America Opioids Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table America Opioids Drug Consumption Value by Region, 2015-2020 (Million USD)
Table America Opioids Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Asia Opioids Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Asia Opioids Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Asia Opioids Drug Revenue by Type, 2015-2020 (Million USD)
Table Asia Opioids Drug Production Volume by Type, 2015-2020 (Volume)
Table Asia Opioids Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Asia Opioids Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Asia Opioids Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Asia Opioids Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Oceania Opioids Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Oceania Opioids Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Oceania Opioids Drug Revenue by Type, 2015-2020 (Million USD)
Table Oceania Opioids Drug Production Volume by Type, 2015-2020 (Volume)
Table Oceania Opioids Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Oceania Opioids Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Oceania Opioids Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Oceania Opioids Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Africa Opioids Drug Production Volume (Volume), Ex-factory Price, Revenue (Million USD) and Gross Margin (%) List, 2015-2020
Table Africa Opioids Drug Consumption Volume (Volume), Terminal Price and Consumption Value (Million USD) List, 2015-2020
Table Africa Opioids Drug Revenue by Type, 2015-2020 (Million USD)
Table Africa Opioids Drug Production Volume by Type, 2015-2020 (Volume)
Table Africa Opioids Drug Consumption Value by End-Use, 2015-2020 (Million USD)
Table Africa Opioids Drug Consumption Volume by End-Use, 2015-2020 (Volume)
Table Africa Opioids Drug Consumption Value by Region, 2015-2020 (Million USD)
Table Africa Opioids Drug Consumption Volume by Region, 2015-2020 (Volume)
Table Global Opioids Drug Revenue by Type, 2020E-2025F (Million USD)
Table Global Opioids Drug Production Volume by Type, 2020E-2025F (Volume)
Table Global Opioids Drug Consumption Value by End-Use, 2020E-2025F (Million USD)
Table Global Opioids Drug Consumption Volume by End-Use, 2020E-2025F (Volume)
Table Global Opioids Drug Consumption Value by Region, 2020E-2025F (Million USD)
Table Global Opioids Drug Consumption Volume by Region, 2020E-2025F (Volume)
Table Purdue Pharma Overview List
Table Business Operation of Purdue Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table J&J Overview List
Table Business Operation of J&J (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Overview List
Table Business Operation of Teva (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mylan Overview List
Table Business Operation of Mylan (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Depomed Overview List
Table Business Operation of Depomed (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table INSYS Overview List
Table Business Operation of INSYS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Endo Overview List
Table Business Operation of Endo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pfizer Overview List
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hikma Overview List
Table Business Operation of Hikma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mallinckrodt Overview List
Table Business Operation of Mallinckrodt (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Pernix Overview List
Table Business Operation of Pernix (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Egalet Overview List
Table Business Operation of Egalet (Sales Revenue, Cost, Gross Margin)
Table Vistapharm Overview List
Table Business Operation of Vistapharm (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Opioids Drug Sales Revenue 2015-2020E, by Companies, in USD Million
Table Global Opioids Drug Sales Revenue Share, 2015-2020E, by Companies, in USD
Table Global Opioids Drug Sales Volume by Companies, 2015-2020E (Volume)
Table Global Opioids Drug Sales Volume Share by Companies, 2015-2020E (Volume)

List of Figures

Figure Europe Opioids Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Europe Opioids Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure America Opioids Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure America Opioids Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Asia Opioids Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure AsiaOpioids Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Oceania Opioids Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Oceania Opioids Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Africa Opioids Drug Market Size and Growth Rate, 2015E-2020F (Million USD)
Figure Africa Opioids Drug Market Forecast and Growth Rate, 2020E-2025F (Million USD)
Figure Global Opioids Drug Revenue Share by Type in 2020 (Million USD)
Figure Global Opioids Drug Production Volume Share by Type in 2020 (Volume)
Figure Global Opioids Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Global Opioids Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Europe Opioids Drug Revenue Share by Type in 2020 (Million USD)
Figure Europe Opioids Drug Production Volume Share by Type in 2020 (Volume)
Figure Europe Opioids Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Europe Opioids Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure America Opioids Drug Revenue Share by Type in 2020 (Million USD)
Figure America Opioids Drug Production Volume Share by Type in 2020 (Volume)
Figure America Opioids Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure America Opioids Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Asia Opioids Drug Revenue Share by Type in 2020 (Million USD)
Figure Asia Opioids Drug Production Volume Share by Type in 2020 (Volume)
Figure Asia Opioids Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Asia Opioids Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Oceania Opioids Drug Revenue Share by Type in 2020 (Million USD)
Figure Oceania Opioids Drug Production Volume Share by Type in 2020 (Volume)
Figure Oceania Opioids Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Oceania Opioids Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Africa Opioids Drug Revenue Share by Type in 2020 (Million USD)
Figure Africa Opioids Drug Production Volume Share by Type in 2020 (Volume)
Figure Africa Opioids Drug Consumption Value Share by End-Use in 2020 (Million USD)
Figure Africa Opioids Drug Consumption Volume Share by End-Use in 2020 (Volume)
Figure Global Opioids Drug Revenue and Growth Rate Forecast 2020E-2025F (Million USD)
Figure Global Opioids Drug Production Volume and Growth Rate Forecast 2020E-2025F (Volume)
Figure Global Opioids Drug Revenue Share by Type in 2025 (Million USD)
Figure Global Opioids Drug Production Volume Share by Type in 2025 (Volume)
Figure Global Opioids Drug Consumption Value Share by End-Use in 2025 (Million USD)
Figure Global Opioids Drug Consumption Value Share by Region in 2025 (Million USD)
Figure Global Opioids Drug Consumption Volume Share by Region in 2025 (Volume)
  • Global Pain Management Drugs Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 93
    Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about The drugs for pain management. The global Pain Management Drugs market was valued at US$ 35360 million in 2023 and is anticipated to reach US$ 44550 million by 2030, witnessing a CAGR of 3.3% during The forecast period 2024-2030. The leading manufacturers in The industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13......
  • Global Pain Management Drugs Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 131
    According to our LPI (LP Information) latest study, the global Pain Management Drugs market size was valued at US$ 34590 million in 2023. With growing demand in downstream market, the Pain Management Drugs is forecast to a readjusted size of US$ 43780 million by 2030 with a CAGR of 3.4% during review period. The research report highlights the growth potential of the global Pain Management Drugs market. Pain Management Drugs are expected to show stable growth in the future market. However......
  • Global Opioids Drug Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Opioids Drug market size was valued at US$ 9831.4 million in 2023. With growing demand in downstream market, the Opioids Drug is forecast to a readjusted size of US$ 8616.1 million by 2030 with a CAGR of -1.9% during review period. The research report highlights the growth potential of the global Opioids Drug market. Opioids Drug are expected to show stable growth in the future market. However, product differentiation, reduci......
  • Global Methadone Hydrochloride Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Methadone Hydrochloride market size was valued at US$ 63 million in 2023. With growing demand in downstream market, the Methadone Hydrochloride is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 5.0% during review period. The research report highlights the growth potential of the global Methadone Hydrochloride market. Methadone Hydrochloride are expected to show stable growth in the future market. Howev......
  • Global Opioids Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 112
    Market Overview of Global Opioids Drugs market: According to our latest research, the global Opioids Drugs market looks promising in the next 5 years. As of 2022, the global Opioids Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescript......
  • Global Opioids Drug Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Opioids Drug market size was valued at USD 10340 million in 2023 and is forecast to a readjusted size of USD 9156.6 million by 2030 with a CAGR of -1.7% during review period. Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. The......
  • Global Methadone Hydrochloride Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 87
    According to our (Global Info Research) latest study, the global Methadone Hydrochloride market size was valued at USD 66 million in 2023 and is forecast to a readjusted size of USD 90 million by 2030 with a CAGR of 4.6% during review period. Methadone Hydrochloride is a white, crystalline material that is water-soluble. It is an opioid used to treat pain or as maintenance therapy to help with detoxification in people with opioid dependence. Market Competition is not intense, as t......
  • Global Pain Management Drugs Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 131
    According to our (Global Info Research) latest study, the global Pain Management Drugs market size was valued at USD 36380 million in 2023 and is forecast to a readjusted size of USD 45230 million by 2030 with a CAGR of 3.2% during review period. Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques. This report is mainly about the drugs for pain management. The leading manufacturers in the industry are GSK, Pfizer and Grune......
  • Global Fibromyalgia Drugs Market Research Report 2023, Forecast to 2028
    Published: 28-Dec-2023        Price: US 2680 Onwards        Pages: 167
    The FDA has approved three drugs to treat fibromyalgia: the antidepressants duloxetine (Cymbalta) and milnacipran (Savella), plus the anti-seizure medicine pregabalin (Lyrica). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging oppo......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs